| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 147, 654-667, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
S Kume, M Takeya, T Mori, N Araki, H Suzuki, S Horiuchi, T Kodama, Y Miyauchi and K Takahashi
Second Department of Pathology, Kumamoto University School of Medicine, Japan.
To elucidate the deposition of advanced glycation end products (AGEs) in aortic atherosclerosis, aortic walls were obtained from 25 autopsy cases and examined immunohistochemically and immunoelectron microscopically with a monoclonal antibody specific for AGEs, 6D12. Among the autopsy cases, atherosclerotic lesions were found in the aortas of 22 cases and were composed of diffuse intimal thickening, fatty streaks, atherosclerotic plaques, and/or complicated lesions. In these cases, intracellular AGE accumulation was demonstrated in the intimal lesions of aortic atherosclerosis in 12 cases. Compared with the diffuse intimal thickening, intracellular AGE accumulation was marked in the fatty streaks and atherosclerotic plaques. Immunohistochemical double staining with 6D12 and monoclonal antibodies for macrophages or muscle actin or a polyclonal antibody for scavenger receptors demonstrated that the AGE accumulation in macrophages or their related foam cells was marked in the diffuse intimal thickening and fatty streak lesions and that almost all macrophages and macrophage- derived foam cells possessed scavenger receptors. Immunoelectron microscopic observation revealed the localization of 6D12-positive reaction in lysosomal lipid vacuoles or electron-dense granules of the foam cells. These results indicate that AGE accumulation occurs in macrophages, smooth muscle cells, and their related foam cells.
This article has been cited by other articles:
 |
|
 |
|
  R. NAGAI, Y. FUJIWARA, K. MERA, K. MOTOMURA, Y. IWAO, K. TSURUSHIMA, M. NAGAI, K. TAKEO, M. YOSHITOMI, M. OTAGIRI, et al. Usefulness of Antibodies for Evaluating the Biological Significance of AGEs Ann. N.Y. Acad. Sci., April 1, 2008; 1126(1): 38 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. FUJIWARA, N. KIYOTA, K. MOTOMURA, K. MERA, M. TAKEYA, T. IKEDA, and R. NAGAI Some Natural Compounds Enhance N{varepsilon}-(Carboxymethyl)lysine Formation Ann. N.Y. Acad. Sci., April 1, 2008; 1126(1): 152 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. MERA, Y. FUJIWARA, M. OTAGIRI, N. SAKATA, and R. NAGAI Immunological Detection of N{omega}-(Carboxymethyl)arginine by a Specific Antibody Ann. N.Y. Acad. Sci., April 1, 2008; 1126(1): 155 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Maleszewski, J. Lu, K. Fox-Talbot, and M. K. Halushka Robust Immunohistochemical Staining of Several Classes of Proteins in Tissues Subjected to Autolysis J. Histochem. Cytochem., June 1, 2007; 55(6): 597 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Kaji, R Nagai, S Amano, Y Takazawa, M Fukayama, and T Oshika Advanced glycation end product deposits in climatic droplet keratopathy Br. J. Ophthalmol., January 1, 2007; 91(1): 85 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nakano, K. Fukuhara-Takaki, T. Jono, K. Nakajou, N. Eto, S. Horiuchi, M. Takeya, and R. Nagai Association of Advanced Glycation End Products with A549 Cells, a Human Pulmonary Epithelial Cell Line, Is Mediated by a Receptor Distinct from the Scavenger Receptor Family and RAGE. J. Biochem., May 1, 2006; 139(5): 821 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ge, Q. Jia, C. Liang, Y. Luo, D. Huang, A. Sun, K. Wang, Y. Zou, and H. Chen Advanced Glycosylation End Products Might Promote Atherosclerosis Through Inducing the Immune Maturation of Dendritic Cells Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2157 - 2163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. I. MOREIRA, M. A. SMITH, X. ZHU, A. NUNOMURA, R. J. CASTELLANI, and G. PERRY Oxidative Stress and Neurodegeneration Ann. N.Y. Acad. Sci., June 1, 2005; 1043(1): 545 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Falcone, E. Emanuele, A. D'Angelo, M. P. Buzzi, C. Belvito, M. Cuccia, and D. Geroldi Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1032 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Kilhovd, A. Juutilainen, S. Lehto, T. Ronnemaa, P. A. Torjesen, K. I. Birkeland, T. J. Berg, K. F. Hanssen, and M. Laakso High Serum Levels of Advanced Glycation End Products Predict Increased Coronary Heart Disease Mortality in Nondiabetic Women but not in Nondiabetic Men: A Population-Based 18-Year Follow-Up Study Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 815 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Koito, T. Araki, S. Horiuchi, and R. Nagai Conventional Antibody against N{varepsilon}-(Carboxymethyl)Lysine (CML) Shows Cross-Reaction to N{varepsilon}-(Carboxyethyl)Lysine (CEL): Immunochemical Quantification of CML with a Specific Antibody J. Biochem., December 1, 2004; 136(6): 831 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Sommeijer, A. Beganovic, C. G. Schalkwijk, H. Ploegmakers, C. M. van der Loos, B. E. van Aken, H. ten Cate, and A. C. van der Wal More Fibrosis and Thrombotic Complications but Similar Expression Patterns of Markers for Coagulation and Inflammation in Symptomatic Plaques from DM2 Patients J. Histochem. Cytochem., September 1, 2004; 52(9): 1141 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Beauchamp, S.-E. Michaud, L. Li, M. R. Sartippour, and G. Renier Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression J. Lipid Res., September 1, 2004; 45(9): 1749 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Jono, R. Nagai, X. Lin, N. Ahmed, P. J. Thornalley, M. Takeya, and S. Horiuchi N{varepsilon}-(Carboxymethyl)lysine and 3-DG-Imidazolone Are Major AGE Structures in Protein Modification by 3-Deoxyglucosone J. Biochem., September 1, 2004; 136(3): 351 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Sasso, O. Carbonara, R. Nasti, B. Campana, R. Marfella, M. Torella, G. Nappi, R. Torella, and D. Cozzolino Glucose Metabolism and Coronary Heart Disease in Patients With Normal Glucose Tolerance JAMA, April 21, 2004; 291(15): 1857 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Monaco and E. Paleolog Nuclear factor {kappa}B: a potential therapeutic target in atherosclerosis and thrombosis Cardiovasc Res, March 1, 2004; 61(4): 671 - 682. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bouma, L. M. J. Kroon-Batenburg, Y.-P. Wu, B. Brunjes, G. Posthuma, O. Kranenburg, P. G. de Groot, E. E. Voest, and M. F. B. G. Gebbink Glycation Induces Formation of Amyloid Cross-{beta} Structure in Albumin J. Biol. Chem., October 24, 2003; 278(43): 41810 - 41819. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Anderson and J. W. Heinecke Production of N{varepsilon}-(Carboxymethyl)Lysine Is Impaired in Mice Deficient in NADPH Oxidase: A Role for Phagocyte-Derived Oxidants in the Formation of Advanced Glycation End Products During Inflammation Diabetes, August 1, 2003; 52(8): 2137 - 2143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nagai, C. M. Hayashi, L. Xia, M. Takeya, and S. Horiuchi Identification in Human Atherosclerotic Lesions of GA-pyridine, a Novel Structure Derived from Glycolaldehyde-modified Proteins J. Biol. Chem., December 6, 2002; 277(50): 48905 - 48912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Napoli, L. O. Lerman, F. de Nigris, J. Loscalzo, and L. J. Ignarro Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cells J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1515 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nagai, Y. Unno, M. C. Hayashi, S. Masuda, F. Hayase, N. Kinae, and S. Horiuchi Peroxynitrite Induces Formation of N{varepsilon}-(Carboxymethyl)Lysine by the Cleavage of Amadori Product and Generation of Glucosone and Glyoxal From Glucose: Novel Pathways for Protein Modification by Peroxynitrite Diabetes, September 1, 2002; 51(9): 2833 - 2839. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C.B. Tan, W.-S. Chow, V. H.G. Ai, C. Metz, R. Bucala, and K. S.L. Lam Advanced Glycation End Products and Endothelial Dysfunction in Type 2 Diabetes Diabetes Care, June 1, 2002; 25(6): 1055 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kanauchi, N. Tsujimoto, and T. Hashimoto Advanced Glycation End Products in Nondiabetic Patients With Coronary Artery Disease Diabetes Care, September 1, 2001; 24(9): 1620 - 1623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Stadtman Protein Oxidation in Aging and Age-Related Diseases Ann. N.Y. Acad. Sci., April 1, 2001; 928(1): 22 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sakata, N. Uesugi, S. Takebayashi, R. Nagai, T. Jono, S. Horiuchi, M. Takeya, H. Itabe, T. Takano, T. Myint, et al. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis Cardiovasc Res, February 1, 2001; 49(2): 466 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kislinger, C. Fu, B. Huber, W. Qu, A. Taguchi, S. Du Yan, M. Hofmann, S. F. Yan, M. Pischetsrieder, D. Stern, et al. Nepsilon -(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression J. Biol. Chem., October 29, 1999; 274(44): 31740 - 31749. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tajima, T. Kawanami, R. Nagai, S. Horiuchi, and T. Kato Hereditary ceruloplasmin deficiency increases advanced glycation end products in the brain Neurology, August 1, 1999; 53(3): 619 - 619. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Al-Abed, T. Mitsuhashi, H. Li, J. A. Lawson, G. A. FitzGerald, H. Founds, T. Donnelly, A. Cerami, P. Ulrich, and R. Bucala Inhibition of advanced glycation endproduct formation by acetaldehyde: Role in the cardioprotective effect of ethanol PNAS, March 2, 1999; 96(5): 2385 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. ONORATO, S. R. THORPE, and J. W. BAYNES Immunohistochemical and ELISA Assays for Biomarkers of Oxidative Stress in Aging and Disease Ann. N.Y. Acad. Sci., November 20, 1998; 854(1): 277 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Miyazaki, N. Sakashita, O. Lee, K. Takahashi, S. Horiuchi, H. Hakamata, P. M. Morganelli, C. C. Y. Chang, and T.-Y. Chang Expression of ACAT-1 Protein in Human Atherosclerotic Lesions and Cultured Human Monocytes-Macrophages Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1568 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sano, T. Higashi, K. Matsumoto, J. Melkko, Y. Jinnouchi, K. Ikeda, Y. Ebina, H. Makino, B. Smedsrod, and S. Horiuchi Insulin Enhances Macrophage Scavenger Receptor-mediated Endocytic Uptake of Advanced Glycation End Products J. Biol. Chem., April 10, 1998; 273(15): 8630 - 8637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Shamsi, A. Partal, C. Sady, M. A. Glomb, and R. H. Nagaraj Immunological Evidence for Methylglyoxal-derived Modifications in Vivo. DETERMINATION OF ANTIGENIC EPITOPES J. Biol. Chem., March 20, 1998; 273(12): 6928 - 6936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bierhaus, T. Illmer, M. Kasper, T. Luther, P. Quehenberger, H. Tritschler, P. Wahl, R. Ziegler, M. Muller, and P. P. Nawroth Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGE Circulation, October 7, 1997; 96(7): 2262 - 2271. [Abstract] [Full Text]
|
|
|
|
|
|
J. R. Requena, M. U. Ahmed, C. W. Fountain, T. P. Degenhardt, S. Reddy, C. Perez, T. J. Lyons, A. J. Jenkins, J. W. Baynes, and S. R. Thorpe Carboxymethylethanolamine, a Biomarker of Phospholipid Modification during the Maillard Reaction in Vivo J. Biol. Chem., July 11, 1997; 272(28): 17473 - 17479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shoda, S. Miyata, B.-F. Liu, H. Yamada, T. Ohara, K. Suzuki, M. Oimomi, and M. Kasuga Inhibitory Effects of Tenilsetam on the Maillard Reaction Endocrinology, May 1, 1997; 138(5): 1886 - 1892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Miyata, B.-F. Liu, H. Shoda, T. Ohara, H. Yamada, K. Suzuki, and M. Kasuga Accumulation of Pyrraline-modified Albumin in Phagocytes due to Reduced Degradation by Lysosomal Enzymes J. Biol. Chem., February 14, 1997; 272(7): 4037 - 4042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ohgami, R. Nagai, M. Ikemoto, H. Arai, A. Kuniyasu, S. Horiuchi, and H. Nakayama CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products J. Biol. Chem., January 26, 2001; 276(5): 3195 - 3202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Chellan and R. H. Nagaraj Early Glycation Products Produce Pentosidine Cross-links on Native Proteins. NOVEL MECHANISM OF PENTOSIDINE FORMATION AND PROPAGATION OF GLYCATION J. Biol. Chem., February 2, 2001; 276(6): 3895 - 3903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ohgami, R. Nagai, A. Miyazaki, M. Ikemoto, H. Arai, S. Horiuchi, and H. Nakayama Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products J. Biol. Chem., April 13, 2001; 276(16): 13348 - 13355. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
